Abstract: A method for forming a semiconductor die, includes forming an interlayer dielectric layer on a substrate having a semiconductor die region, a seal-ring region, and a scribe line region, forming a metal pad and a test pad on the interlayer dielectric layer, forming a passivation dielectric layer on the interlayer dielectric layer, the metal pad, and the test pad, first etching the passivation dielectric layer and the interlayer dielectric layer existing between the seal-ring region and the scribe line region to a predetermined depth using a plasma etching process, second etching the passivation dielectric layer to expose the metal pad and the test pad, forming a bump on the metal pad, and dicing the substrate while removing the scribe line region by mechanical sawing.

Abstract: An embodiment relates to a crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido [4,3-d]pyrimidin-5(6H)-one hydrochloride which can effectively suppress FLT3 and has excellent stability even in a high temperature and humid environment, and a method for preparing same.

Abstract: A pyrrolo(pyrazolo)pyrimidine compound of Formula 1, a pharmaceutically acceptable salt, a hydrate, a solvate, a prodrug, and an isomer, and pharmaceutical compositions containing the compound are disclosed. The compound of Formula 1 shows excellent LRRK2 inhibitory activity.

Abstract: The present invention relates to a pyrrolo(pyrazolo)pyrimidine derivative having efficacy as an LRRK2 inhibitor, a preparation method therefor, and a pharmaceutical composition for preventing or treating degenerative brain diseases, containing the same.

Abstract: An embodiment relates to a crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3 -d]pyrimidin-5 (6H)-one hydrochloride which can effectively suppress FLT3 and has excellent stability even in a high temperature and humid environment, and a method for preparing same.

Abstract: Pyridopyrimidinone derivatives and pharmaceutical compositions containing the same for use as an Axl inhibitor for the treatment of a disease or condition mediated by Axl such as cancer and metastasis, are disclosed. Also disclosed are methods for treating a Axl-mediated disease or condition by administering to a subject a therapeutically effective amount of the pyridopyrimidinone derivative.

Abstract: An apparatus for generating olfactory information related to multimedia content may comprise a processor. The processor may receive multimedia content, extract an odor image or an odor sound included in the multimedia content, and generate representative data related to the odor image or the odor sound by describing information on the extracted odor image or odor sound in a data format sharable by a media thing.

Abstract: An apparatus and method for generating olfactory information. The apparatus for generating olfactory information generates olfactory information that can be shared between a real world and at least one virtual world. The apparatus for generating olfactory information includes a sensor and a processor. The sensor recognizes a real-world odor, and acquires the original data of the result of the detection of the real-world odor. The processor acquires representative data including the evaluation of the quantitative numerical value of the real-world odor by analyzing the original data, and generates real-world olfactory information including both the original data and the representative data.

Abstract: Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).

Abstract: Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).

Abstract: Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrropyrimidine and pyrazolopyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof that are useful for treating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrropyrimidine and pyrazolopyrimidine derivatives.

Abstract: Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrropyrimidine and pyrazolopyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof that are useful for treating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrropyrimidine and pyrazolopyrimidine derivatives.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.

Abstract: The present invention relates to a direct memory access controller, specifically to a direct memory access controller which controls the direct memory access between internal modules and high speed external memories such as SDRAM(Synchronous Dynamic RAM) in high speed digital signal processors having burst transmission feature. The direct memory access controller comprises a plurality of direct memory access controller circuits, a direct memory access bus arbiter, and a direct memory access bus bridge connecting a direct memory access master bus and a direct memory access slave bus and providing a data transmission path between external high speed memories and input/output devices according to a signal from the direct memory access controller which is connected to said master bus.

Abstract: A discrete cosine transform circuit for processing an 8.times.8 block and two 4.times.8 blocks, comprising a first shuffle circuit for performing a first one-dimensional discrete cosine transform, a second shuffle circuit for performing a second one-dimensional discrete cosine transform, a first multiplexing circuit for selecting inputs to input terminals of adders/subtracters in the second shuffle circuit according to an input block size, ROMs for storing a data table therein to support all cosine matrices to perform a matrix multiplication operation based on the input block size, and a second multiplexing circuit for selecting a desired one of outputs from the ROMs according to the input block size. Therefore, according to the present invention, common and different parts for the process of two different block sizes are all implemented on a single circuit and controlled to process forward and inverse discrete cosine transforms.

Abstract: Disclosed is a quantization/inverse quantization circuit including a differential pulse code modulator (DPCM). Video CODEC standards (i.e., JPEG, H.261, H.263, MPEG-1, and MPEG-2) include various functions for an image compression and an image reconstruction. The conventional quantization/inverse quantization circuit has been designed to be fit for only one desired standard, so that the quantization/inverse quantization circuit used for one standard cannot be directly used for another standard. Accordingly, in relation to a difference between standards and required function therebetween in order to use the present invention in all video CODEC standards, the present invention discloses a quantization/inverse quantization circuit which can support all modes (i.e., a quantization mode in coding, an inverse quantization mode in decoding, and a reconstruction mode) by employing one quantization circuit as a quantization/inverse quantization circuit which can be used in all video CODEC standards.